Daiichi Sankyo opens subsidiary in Puerto Rico
This article was originally published in Scrip
Daiichi Sankyohas opened a subsidiary in Puerto Rico, the company announced yesterday. Daiichi Sankyo de Puerto Rico, based in San Juan, will act as a sales agent for its parent company. Its regional director Jose Vasquez said that the new subsidiary marked the company's growth, fuelled by its expanding portfolio and robust pipeline of new compounds. Daiichi Sankyo is currently focusing its R&D on cardiovascular and metabolic disease. Its marketed products centre on hypertension, cholesterol and type 2 diabetes.